Screener
Replimune Group REPL Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Replimune Group’s 10-Q, filed February 3, 2026.
- Filed
- Feb 3, 2026, 8:12 AM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q4 2025
- Accession
- 0001628280-26-004805
| Line item | December 31, 2025 | March 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 14) | ||
| Stockholders' equity | ||
| Common stock, $0.001 par value; 150,000,000 shares authorized as of December 31, 2025 and March 31, 2025; 79,631,167 and 77,085,024 shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively | 79 | 77 |
| Additional paid-in capital | 1,394,198 | 1,358,897 |
| Accumulated deficit | (1,189,302) | (948,579) |
| Accumulated other comprehensive income | 5,564 | 5,448 |
| Total stockholders' equity | $210,539 | $415,843 |
| Total liabilities and stockholders' equity | $333,590 | $551,328 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Replimune Group's total equity?
- Replimune Group (REPL) reported total equity of $210.54M in Q4 2025.
- How has Replimune Group's total equity changed year-over-year?
- Replimune Group's total equity decreased by 56.4% year-over-year, from $482.37M to $210.54M.
- What is the long-term trend for Replimune Group's total equity?
- Over 4 years (2021 to 2025), Replimune Group's total equity has grown at a -4.4% compound annual growth rate (CAGR), from $498.73M to $415.84M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Replimune Group's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude